Watching tuberculosis bacteria enter the lung in real time

Tuberculosis is caused by Mycobacterium tuberculosis, but the earliest moments after bacteria reach the lung—the first hours and days when host and microbe first meet—have been difficult to study directly. Biosafety concerns and technical limits have long kept scientists from watching live mycobacteria move and interact inside the breathing lung. William R. Jacobs and colleagues addressed that gap by creating a practical protocol that makes real-time imaging possible. Using preparation of bacteria for intravenous infection and intravital imaging in reporter mice, the team built a system that lets researchers follow bacteria as they enter the lung circulation, clump together, block tiny blood vessels, spread into the lung tissue, and are taken up by lung macrophages. Importantly, the approach uses safe Mtb surrogates so the observations can be done under more manageable biosafety conditions. The result is the first usable platform to visualize early Mycobacterium tuberculosis behavior in the lung of a living animal, opening a new window on the very start of infection.

The core of the work is a stepwise experimental setup that matches bacterial preparation for intravenous infection with live, high-resolution intravital imaging in reporter mice. This combination enabled direct visualization of rapid bacterial entry into the pulmonary vasculature, subsequent aggregation, and vascular occlusion, followed by dissemination into the lung parenchyma and macrophage uptake over three days post-infection. By watching these events in real time, the researchers documented how bacteria localize and form aggregates inside the circulation, how those aggregates can interact with and obstruct small vessels, and how lung macrophages encounter and engulf bacteria during the initial hours to days following infection. The protocol provides the first practical platform for real-time intravital imaging of mycobacteria in the lung and establishes a foundation for subsequent mechanistic work on bacterial physiology, host recognition, and immune-mediated clearance using safe Mtb surrogates.

This advance matters because it overcomes long-standing biosafety and technical barriers that prevented live imaging of mycobacterial infection in the lung. With intravital imaging in reporter mice now practical, scientists can pose and test new questions about how Mycobacterium tuberculosis behaves the moment it arrives in the lung vasculature, how aggregates form and influence local blood flow, and how lung macrophages recognize and clear incoming bacteria. The platform sets up controlled, real-time studies of bacterial physiology and host responses under safe experimental conditions, offering a reproducible way to trace early host-pathogen interactions. While the work uses safe Mtb surrogates rather than fully virulent strains, the insights gained can shape mechanistic hypotheses and experimental directions that ultimately aim to improve our understanding of tuberculosis pathogenesis and immune defense in the lung.